Evaluation of the Potential Diagnostic Utility of the Determination of Selected Immunological and Molecular Parameters in Patients with Ovarian Cancer

被引：2
作者：
Englisz, Aleksandra [1 ]
Smycz-Kubanska, Marta [2 ]
Mielczarek-Palacz, Aleksandra [2 ]
机构：
[1] Med Univ Silesia, Doctoral Sch, PL-40055 Katowice, Poland
[2] Med Univ Silesia, Fac Pharmaceut Sci Sosnowiec, Dept Immunol & Serol, PL-40055 Katowice, Poland
来源：
DIAGNOSTICS | 2023年 / 13卷 / 10期
关键词：
ovarian cancer; potential biomarkers; galectins; adipocytokines; miRNA; PREDICTS POOR-PROGNOSIS; STEM-CELLS; PREOPERATIVE DIAGNOSIS; MONOCLONAL-ANTIBODY; MALIGNANCY INDEX; CD24; EXPRESSION; FOLLOW-UP; SERUM; HE-4; MARKER;
D O I：
10.3390/diagnostics13101714
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Ovarian cancer is one of the most serious challenges in modern gynaecological oncology. Due to its non-specific symptoms and the lack of an effective screening procedure to detect the disease at an early stage, ovarian cancer is still marked by a high mortality rate among women. For this reason, a great deal of research is being carried out to find new markers that can be used in the detection of ovarian cancer to improve early diagnosis and survival rates of women with ovarian cancer. Our study focuses on presenting the currently used diagnostic markers and the latest selected immunological and molecular parameters being currently investigated for their potential use in the development of new diagnostic and therapeutic strategies.
引用
收藏
页数：23
相关论文
共 165 条
  • [1] Abdelwahab M.M., 2019, J OBSTET GYNECOL, V9, P937, DOI [10.4236/ojog.2019.97091, DOI 10.4236/OJOG.2019.97091]
  • [2] Al Musalhi Khawla, 2016, Oman Med J, V31, P336, DOI 10.5001/omj.2016.68
  • [3] The Accuracy of Risk Malignancy Index in Prediction of Malignancy in Women with Adnexal Mass in Basrah, Iraq
    Al-Asadi, J. N.
    Al-Maliki, S. K.
    Al-Dahhhan, F.
    Al-Naama, L.
    Suood, F.
    [J]. NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2018, 21 (10) : 1254 - 1259
  • [4] Sensitivity and specificity of microRNA-204, CA125, and CA19.9 as biomarkers for diagnosis of ovarian cancer
    Ali, Fahmy T.
    Soliman, Reham M.
    Hassan, Nahla S.
    Ibrahim, Ahmed M.
    El-Gizawy, Mayada M.
    Mandoh, Abd Allah Y.
    Ibrahim, Ehab A.
    [J]. PLOS ONE, 2022, 17 (08):
  • [5] Roles of microRNAs in Ovarian Cancer Tumorigenesis: Two Decades Later, What Have We Learned?
    Alshamrani, Ali A.
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [6] Alwani A., 2021, POST PY BIOCH, V67
  • [7] Anastasi Emanuela, 2017, Asian Pac J Cancer Prev, V18, P1277
  • [8] Is CA72-4 a Useful Biomarker in Differential Diagnosis between Ovarian Endometrioma and Epithelial Ovarian Cancer?
    Anastasi, Emanuela
    Manganaro, Lucia
    Granato, Teresa
    Panici, Pierluigi Benedetti
    Frati, Luigi
    Porpora, Maria Grazia
    [J]. DISEASE MARKERS, 2013, 2013 : 331 - 335
  • [9] Clinical significance of circulating omentin levels in various malignant tumors: Evidence from a systematic review and meta-analysis
    Arjmand, Mohammad-Hassan
    Moradi, Ali
    Akbari, Abolfazl
    Mehrad-Majd, Hassan
    [J]. CYTOKINE, 2020, 125
  • [10] New Predictive Biomarkers for Ovarian Cancer
    Atallah, Ghofraan Abdulsalam
    Abd Aziz, Nor Haslinda
    Teik, Chew Kah
    Shafiee, Mohamad Nasir
    Kampan, Nirmala Chandralega
    [J]. DIAGNOSTICS, 2021, 11 (03)
12345678910